Hussman Strategic Advisors’s Astrana Health ASTH Stock Holding History

Hussman Strategic Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Sell	42,000 -21,000	-33%	-$756K	0.45%	106
2026 Q1	$1.54M	Hold	63,000	–	–	0.33%	136
2025 Q4	$1.56M	Buy	63,000 +42,000	+200%	+$1.12M	0.38%	120
2025 Q3	$595K	Sell	21,000 -105,000	-83%	-$2.85M	0.13%	236
2025 Q2	$3.13M	Buy	126,000 +42,000	+50%	+$1.18M	0.72%	43
2025 Q1	$2.6M	Buy	84,000 +21,000	+33%	+$700K	0.63%	47
2024 Q4	$1.99M	Buy	+63,000	New	+$2.99M	0.59%	65

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hussman Strategic Advisors's ASTH Position: Q2 2026 in Review

Hussman Strategic Advisors reduced its Astrana Health (ASTH) stake by 33% in Q2 2026, selling an estimated $756K and leaving 42,000 shares worth $1.95M. The position accounts for 0.45% of the portfolio, ranked #106.

Hussman Strategic Advisors first reported a position in ASTH in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.13M in Q2 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Hussman Strategic Advisors held 42,000 shares of Astrana Health worth $1.95M as of Q2 2026.
Hussman Strategic Advisors sold 21,000 Astrana Health shares in Q2 2026, an estimated $756K.
Astrana Health made up 0.45% of Hussman Strategic Advisors's portfolio in Q2 2026, its #106 holding.
Hussman Strategic Advisors first reported a position in Astrana Health in Q4 2024 and has held it in 7 quarters since.
Hussman Strategic Advisors's Astrana Health position peaked at $3.13M in Q2 2025.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.